Cargando…

Feasibility and utility of MRI and dynamic (18)F-FDG-PET in an orthotopic organoid-based patient-derived mouse model of endometrial cancer

BACKGROUND: Pelvic magnetic resonance imaging (MRI) and whole-body positron emission tomography-computed tomography (PET-CT) play an important role at primary diagnostic work-up and in detecting recurrent disease in endometrial cancer (EC) patients, however the preclinical use of these imaging metho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Espedal, Heidi, Berg, Hege F., Fonnes, Tina, Fasmer, Kristine E., Krakstad, Camilla, Haldorsen, Ingfrid S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474962/ https://www.ncbi.nlm.nih.gov/pubmed/34565386 http://dx.doi.org/10.1186/s12967-021-03086-9

Ejemplares similares

Imaging of Preclinical Endometrial Cancer Models for Monitoring Tumor Progression and Response to Targeted Therapy
por: Espedal, Heidi, et al.
Publicado: (2019)

Near-Infrared Fluorescent Imaging for Monitoring of Treatment Response in Endometrial Carcinoma Patient-Derived Xenograft Models
por: Fonnes, Tina, et al.
Publicado: (2020)

Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
por: Berg, Hege F., et al.
Publicado: (2021)

Author Correction: Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis
por: Berg, Hege F., et al.
Publicado: (2021)

Preoperative 18F-FDG PET/CT tumor markers outperform MRI-based markers for the prediction of lymph node metastases in primary endometrial cancer
por: Fasmer, Kristine E., et al.
Publicado: (2020)

Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma
por: Haldorsen, Ingfrid S., et al.
Publicado: (2015)

Plasma growth differentiation factor-15 is an independent marker for aggressive disease in endometrial cancer
por: Engerud, Hilde, et al.
Publicado: (2019)

Preoperative pelvic MRI and 2-[(18)F]FDG PET/CT for lymph node staging and prognostication in endometrial cancer—time to revisit current imaging guidelines?
por: Fasmer, Kristine E., et al.
Publicado: (2022)

A radiogenomics application for prognostic profiling of endometrial cancer
por: Hoivik, Erling A., et al.
Publicado: (2021)

Whole‐Volume Tumor MRI Radiomics for Prognostic Modeling in Endometrial Cancer
por: Fasmer, Kristine E., et al.
Publicado: (2020)

An MRI-Based Radiomic Prognostic Index Predicts Poor Outcome and Specific Genetic Alterations in Endometrial Cancer
por: Jacob, Havjin, et al.
Publicado: (2021)

Development of an Image-Guided Orthotopic Xenograft Mouse Model of Endometrial Cancer with Controllable Estrogen Exposure
por: Konings, Gonda FJ, et al.
Publicado: (2018)

Development of prediction models for lymph node metastasis in endometrioid endometrial carcinoma
por: Berg, Hege F., et al.
Publicado: (2020)

Blood Metabolites Associate with Prognosis in Endometrial Cancer
por: Strand, Elin, et al.
Publicado: (2019)

Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease
por: Lien, Hilde E., et al.
Publicado: (2023)

Corrigendum to “Single-cell profiling of low-stage endometrial cancers identifies low epithelial vimentin expression as a marker of recurrent disease” [EBioMedicine 92 (2023) 104595]
por: Lien, Hilde E., et al.
Publicado: (2023)

MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer
por: Dybvik, Julie Andrea, et al.
Publicado: (2022)

Tumour-microenvironmental blood flow determines a metabolomic signature identifying lysophospholipids and resolvin D as biomarkers in endometrial cancer patients
por: Eritja, Núria, et al.
Publicado: (2017)

Automated segmentation of endometrial cancer on MR images using deep learning
por: Hodneland, Erlend, et al.
Publicado: (2021)

Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study
por: van Weelden, Willem Jan, et al.
Publicado: (2019)

Mismatch repair markers in preoperative and operative endometrial cancer samples; expression concordance and prognostic value
por: Berg, Hege F., et al.
Publicado: (2022)

Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer
por: Berg, Anna, et al.
Publicado: (2016)

MRI‐based radiomic signatures for pretreatment prognostication in cervical cancer
por: Wagner‐Larsen, Kari S., et al.
Publicado: (2023)

What Is the Best Preoperative Imaging for Endometrial Cancer?
por: Haldorsen, Ingfrid S., et al.
Publicado: (2016)

HER2 expression patterns in paired primary and metastatic endometrial cancer lesions
por: Halle, Mari Kyllesø, et al.
Publicado: (2018)

Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancers
por: Berg, Anna, et al.
Publicado: (2017)

High visceral fat percentage is associated with poor outcome in endometrial cancer
por: Mauland, Karen Klepsland, et al.
Publicado: (2017)

Feasibility of (18)FDG PET in the cardiac inflammation
por: Osiecki, Sebastian, et al.
Publicado: (2020)

A Gene Signature Identifying CIN3 Regression and Cervical Cancer Survival
por: Halle, Mari K., et al.
Publicado: (2021)

Patient-Derived Xenograft Models for Endometrial Cancer Research
por: Moiola, Cristian P., et al.
Publicado: (2018)

Interobserver agreement and prognostic impact for MRI–based 2018 FIGO staging parameters in uterine cervical cancer
por: Wagner-Larsen, Kari S., et al.
Publicado: (2022)

A Dual Tracer (18)F-FCH/(18)F-FDG PET Imaging of an Orthotopic Brain Tumor Xenograft Model
por: Fu, Yilong, et al.
Publicado: (2016)

Diagnostic value of (18)F-FDG PET/MRI for staging in patients with endometrial cancer
por: Tsuyoshi, Hideaki, et al.
Publicado: (2020)

Diagnostic value of integrated (18)F-FDG PET/MRI for staging of endometrial carcinoma: comparison with PET/CT
por: Yu, Yang, et al.
Publicado: (2022)

Detection of Recurrence by (18)F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of Disease
por: Ryu, Sang-Young, et al.
Publicado: (2010)

What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?
por: Lura, Njål, et al.
Publicado: (2022)

Diffusion-Weighted MRI and FDG-PET in Diagnosis of Endometrial Stromal Nodule
por: Maruyama, Shunsuke, et al.
Publicado: (2015)

Feasibility of MRI attenuation correction in cardiac FDG-PET
por: Lau, Jeffrey M, et al.
Publicado: (2013)

Predicting tumor recurrence using metabolic indices of (18)F-FDG PET/CT prior to orthotopic liver transplantationfor hepatocellular carcinoma
por: Ding, Enci, et al.
Publicado: (2020)

Preoperative evaluation of residual tumor in patients with endometrial carcinoma by using (18)F-FDG PET/CT
por: Wu, Chunhua, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7dnvasfbtvooi9qa0bahleh2kg